Pancreatic cancer trial combines chemo with immune boosters
Disease control
Completed
This study tested whether adding two immunotherapy drugs (pembrolizumab and defactinib) to standard chemotherapy before and after surgery could help the body fight pancreatic cancer better. It involved 28 people with early-stage, removable pancreatic cancer. The goal was to see i…
Phase: PHASE2 • Sponsor: Lei Zheng • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC